<DOC>
	<DOCNO>NCT00000361</DOCNO>
	<brief_summary>The purpose study determine whether prednisone , methotrexate , cyclophosphamide effective treatment rapidly progressive sensorineural hearing loss ear . This condition call autoimmune inner ear disease ( AIED ) , think hear loss trigger autoimmune process . Treatment attempt suppress control process powerful anti-inflammatory drug . This Phase III , outpatient study . All study participant assign one four different group test experimental use drug . The study schedule run 18 month , minimum 11 visit per participant .</brief_summary>
	<brief_title>Autoimmunity Inner Ear Disease</brief_title>
	<detailed_description />
	<mesh_term>Hearing Loss</mesh_term>
	<mesh_term>Hearing Loss , Sensorineural</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Have sensorineural ( nerve/inner ear ) hearing loss least 30 dB ear , rapidly progress . Are good general health . Are sterile use contraception ( woman childbearing age ) . Are able speak understand English Spanish . Have previous reaction prednisone , history psychiatric reaction corticosteroid . Have use corticosteroid 30 day within past 90 day . Patients corticosteroids least 30 day may eligible . Have significant heart , lung , digestive , blood , neurologic disorder . Have tuberculosis ( TB ) , brittle unstable insulindependent diabetes mellitus , active malignancy prior chemotherapy , pancreatitis , active peptic ulcer disease , kidney failure , history shingle , know ( ) autoimmune disease . Have positive test HIV , hepatitis C B . Have type middle ear disorder . Are breastfeed pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2006</verification_date>
	<keyword>Autoimmune Diseases</keyword>
	<keyword>Cyclophosphamide</keyword>
	<keyword>Hearing</keyword>
	<keyword>Labyrinth Diseases</keyword>
	<keyword>Methotrexate</keyword>
	<keyword>Prednisone</keyword>
</DOC>